Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa2dcc3229e9f09477ac4a10c0ed8425 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
filingDate |
1997-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8b6c126e81324a4d6f9d3ad65b1ab3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46117d86761cc0c09a26533d794a96fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a123182cd21d24cc879162dcf0cfaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8892817a8f1a79ff4421385555cf5a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a74ff89fd5ba7d962c1d73dd627934 |
publicationDate |
1997-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0793965-A2 |
titleOfInvention |
Prophylactic/therapeutic composition for secondary cataract |
abstract |
The present invention is to provide a prophylactic/therapeutic composition for the secondary cataract comprising a polypeptide having an inhibitory activity of cell adhesion and a lactic acid-glycolic acid polymer. n The composition of the present invention inhibits adhesion and extension of lens epithelial cells onto the posterior lens capsule after extraction of lens, and is useful as a prophylactic/therapeutic composition for the secondary cataract in the clinical point of view. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1366758-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9847480-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9847480-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1366758-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6251419-B1 |
priorityDate |
1996-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |